1. Home
  2. COR vs ALC Comparison

COR vs ALC Comparison

Compare COR & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COR
  • ALC
  • Stock Information
  • Founded
  • COR 2001
  • ALC 1945
  • Country
  • COR United States
  • ALC Switzerland
  • Employees
  • COR N/A
  • ALC N/A
  • Industry
  • COR Other Pharmaceuticals
  • ALC Ophthalmic Goods
  • Sector
  • COR Health Care
  • ALC Health Care
  • Exchange
  • COR Nasdaq
  • ALC Nasdaq
  • Market Cap
  • COR 44.4B
  • ALC 41.0B
  • IPO Year
  • COR N/A
  • ALC N/A
  • Fundamental
  • Price
  • COR $245.10
  • ALC $88.60
  • Analyst Decision
  • COR Buy
  • ALC Strong Buy
  • Analyst Count
  • COR 11
  • ALC 14
  • Target Price
  • COR $268.09
  • ALC $102.53
  • AVG Volume (30 Days)
  • COR 1.1M
  • ALC 763.4K
  • Earning Date
  • COR 02-05-2025
  • ALC 02-25-2025
  • Dividend Yield
  • COR 0.90%
  • ALC 0.30%
  • EPS Growth
  • COR N/A
  • ALC 156.61
  • EPS
  • COR 7.53
  • ALC 2.34
  • Revenue
  • COR $293,958,599,000.00
  • ALC $9,761,000,000.00
  • Revenue This Year
  • COR $9.98
  • ALC $5.43
  • Revenue Next Year
  • COR $6.47
  • ALC $6.42
  • P/E Ratio
  • COR $32.45
  • ALC $36.59
  • Revenue Growth
  • COR 12.12
  • ALC 5.25
  • 52 Week Low
  • COR $214.77
  • ALC $74.30
  • 52 Week High
  • COR $253.27
  • ALC $101.10
  • Technical
  • Relative Strength Index (RSI)
  • COR 67.93
  • ALC 65.58
  • Support Level
  • COR $233.61
  • ALC $82.31
  • Resistance Level
  • COR $241.14
  • ALC $83.68
  • Average True Range (ATR)
  • COR 3.99
  • ALC 1.13
  • MACD
  • COR 1.99
  • ALC 0.45
  • Stochastic Oscillator
  • COR 98.80
  • ALC 98.90

About COR Cencora Inc.

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

About ALC Alcon Inc.

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Share on Social Networks: